Magnolol Potentiates Sorafenib-induced Apoptosis and Inhibits Metastatic Signaling in Renal Carcinoma
CHE-CHENG CHANG, MAN-YUN HUNG, YUEH-SHAN WENG, CHIEH-MIN CHANG, FEI-TING HSU, YU-HSIANG CHEN, JIANN-HWA CHEN · 2026
Read Magnolol Potentiates Sorafenib-induced Apoptosis and Inhibits Metastatic Signaling in Renal Carcinoma by CHE-CHENG CHANG, MAN-YUN HUNG, YUEH-SHAN WENG, CHIEH-MIN CHANG, FEI-TING HSU, YU-HSIANG CHEN, JIANN-HWA CHEN (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13531104.txt.
Description
Che-Cheng Chang and co-authors pair a magnolia bark compound with a standard kidney cancer drug and watch the two kill tumor cells together, in a study from 2026. Sorafenib is a frontline targeted drug for renal cell carcinoma, but resistance blunts it. Magnolol, from Magnolia officinalis, has its own anti-cancer record.
In mouse renal cancer cells, the pair cut viability more than either alone, with a synergy score below one. The combination switched on both apoptosis routes, the internal and external death pathways, and raised caspase activity. It also shut down a survival chain running through EGFR, SRC, and NF-kappaB. Migration, invasion, and the shape-shifting markers of metastasis all fell. The authors propose magnolol as an add-on to rescue sorafenib's power.
Catalog record
| CREATOR | CHE-CHENG CHANG, MAN-YUN HUNG, YUEH-SHAN WENG, CHIEH-MIN CHANG, FEI-TING HSU, YU-HSIANG CHEN, JIANN-HWA CHEN |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |